Please Wait.....
Report
North America Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type (Antimalarial Agents, and Diagnostic Test); Route of Administration (Oral, and Parenteral); End User (Hospitals, Specialty Clinics, and Others)
Market Report I 2023-01-24 I 152 Pages I The Insight Partners
The North America malaria treatment market is expected to grow from US$ 765.63 million in 2022 to US$ 996.80 million by 2028. It is estimated to register a CAGR of 4.5% from 2022 to 2028.
Rapid Diagnostic Tests for Malaria is Bolstering the North America Malaria Treatment Market
RDTs for malaria can improve the quality of management of the disease. RDTs are proven to be highly affordable and effective for public health programs implemented in low-resource settings. RDTs are widely used in remote areas with limited access to microscopy services. As a result, there has been a rapid rise in the demand for RDTs for malaria. Several RDTs have been developed to test the presence of malaria parasites in blood samples. Identifying and successfully treating malaria in low-transmission areas is critical to reduce transmission and eliminate the disease. Many companies are engaged in developing a wide range of RDTs with high sensitivities. A few of these developments have taken place in recent years. For instance, in November 2020, researchers from Rice University developed a simple microneedle patch like a bandage to detect malaria. With this development, the researchers have stepped on the path of reducing the disease burden in countries struggling with poor health infrastructure. The microneedles loaded on the patch collect interstitial fluid, which contains several biomarkers that help detect malaria. So, the growing number of rapid diagnostic tests for malaria is driving the North America malaria treatment market .
North America Malaria Treatment Market Overview
The North America malaria treatment market is segmented into the US, Canada, and Mexico. The US is dominating the malaria treatment market in the region. According to the Centers for disease control and prevention (CDC), approximately 2,000 cases are reported annually in the United States, mostly in returning travelers and immigrants. Pregnant women and children under five years of age are at the highest risk of contracting malaria and developing severe diseases. Anopheles mosquitoes capable of transmitting malaria ("vectors") endure in the US. Thus, there is a perpetual risk that malaria transmission can resume in the US. In April 2022, the Global Fund reported that malaria cases and deaths had risen primarily due to stalled funding and disruptions from the COVID-19 pandemic. However, efforts to mitigate these impacts are in progress, with the Global Fund reporting in September 2022 that programs had recovered from declines. US malaria efforts include activities primarily through the US President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator, and other US activities. For instance, according to Global health policy, US funding for malaria control and research activities was ~US$ 1 billion in FY 2022. The US government's goal under the PMI Strategy 2021-2026 is to work and reduce malaria deaths further and decrease malaria morbidity toward the long-term goal of elimination. Thus, growing DVT cases and technological advancements in DVT preventive pumps are driving the market's growth.
North America Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
North America Malaria Treatment Market Segmentation
The North America malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.
Based on treatment, the North America malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.
Based on drug type, the North America malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.
Based on route of administration, the North America malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.
Based on distribution channel, the North America malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.
Based on end user, the North America malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.
Based on country, the North America malaria treatment market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US dominated the market in 2022.
AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, VLP Therapeutics LLC, and Zydus Healthcare Ltd are among the leading companies operating in the North America malaria treatment market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Malaria Treatment Market - By Treatment
1.3.2 North America Malaria Treatment Market - By Drug Type
1.3.3 North America Malaria Treatment Market - By Route of Administration
1.3.4 North America Malaria Treatment Market - By Distribution Channel
1.3.5 North America Malaria Treatment Market - By End User
1.3.6 North America Malaria Treatment Market- By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Malaria Treatment Market- Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Malaria Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Government and Private Sector's Initiatives to Raise Awareness About Malaria
5.2 Market Restraints
5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Future Trends
5.4.1 Rapid Diagnostic Tests
5.5 Impact Analysis
6. Malaria Treatment Market- North America Analysis
6.1 North America Malaria Treatment Market Revenue Forecast and Analysis
7. North America Malaria Treatment Market Analysis - By Treatment
7.1 Overview
7.2 North America Malaria Treatment Market, By Treatment 2021 & 2028 (%)
7.3 Prescription Medications
7.3.1 Overview
7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Chloroquine Phosphate
7.3.3.1 Overview
7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.4 Artemisinin- based Combination Therapies (ACTs)
7.3.4.1 Overview
7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
7.3.5 Atovaquone-Proguanil
7.3.5.1 Overview
7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
7.3.6.1 Overview
7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
7.3.7 Primaquine Phosphate
7.3.7.1 Overview
7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Diagnostic Tests
7.5.1 Overview
7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Malaria Treatment Market Analysis - By Drug Type
8.1 Overview
8.2 North America Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
8.3 Branded
8.3.1 Overview
8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Generics
8.4.1 Overview
8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Malaria Treatment Market Analysis - By Route of Administration
9.1 Overview
9.2 North America Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
9.3 Oral
9.3.1 Overview
9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Parenteral and Intravenous Mode
9.4.1 Overview
9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Malaria Treatment Market Analysis - By Distribution Channel
10.1 Overview
10.2 North America Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
10.3 Direct Tender
10.3.1 Overview
10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Retail Pharmacies
10.5.1 Overview
10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Online Pharmacies
10.6.1 Overview
10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. North America Malaria Treatment Market Analysis - By End User
11.1 Overview
11.2 North America Malaria Treatment Market, By End User 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Homecare
11.5.1 Overview
11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
11.6.1 Overview
11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
12. North America Malaria Treatment Market - Country Analysis
12.1 Overview
12.1.1.1 US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.2 US: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.1.2.1 US: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
12.1.1.1.3 US: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
12.1.1.1.4 US: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.1.5 US: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.1.6 US: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
12.1.1.2 Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.2 Canada: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.2.2.1 Canada: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
12.1.1.2.3 Canada: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
12.1.1.2.4 Canada: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.2.5 Canada: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.2.6 Canada: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
12.1.1.3 Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.2 Mexico: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.3.2.1 Mexico: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
12.1.1.3.3 Mexico: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
12.1.1.3.4 Mexico: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.3.5 Mexico: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.3.6 Mexico: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Zydus Healthcare Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sun Pharmaceutical Industries Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi SA
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GSK Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cipla Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Viatris Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lupin Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AdvaCare Pharma USA LLC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 VLP Therapeutics LLC
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies
Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Malaria Treatment Market Segmentation
Figure 2. North America Malaria Treatment Market Segmentation, By Country
Figure 3. North America Malaria Treatment Market Overview
Figure 4. North America Malaria Treatment Market, By Distribution Channel
Figure 5. North America Malaria Treatment Market, By Country
Figure 6. North America PEST Analysis
Figure 7. North America Malaria Treatment Market impact analysis of driver and restraints
Figure 8. North America Malaria Treatment Market - Revenue Forecast and Analysis
Figure 9. North America Malaria Treatment Market, by Treatment 2021 & 2028 (%)
Figure 10. Prescription Medication: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Chloroquine Phosphate: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Artemisinin- based Combination Therapies (ACTs): North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Atovaquone-Proguanil: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Primaquine Phosphate: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Vaccines: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Diagnostic Tests: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
Figure 21. Branded: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Generics: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
Figure 24. Oral: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Parenteral and Intravenous Mode: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. North America Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
Figure 27. Direct Tender: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Hospital Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Retail Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Online Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. North America Malaria Treatment Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Specialty Clinics: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Homecare: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. North America: Malaria Treatment Market, by Key Country - Revenue (2021) (US$ Million)
Figure 38. North America: Malaria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security